A longitudinal follow-up study of a type 2 diabetes “lost to follow-up” cohort – positive effect on glycaemic control after changes in medication

References

• Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016 Jul 22;10:1299–7.
   PubMed Web of Science ®Google Scholar
• Feldman BS, Cohen-Stavi CJ, Leibowitz M, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS One. 2014 Sep 26;9(9):e108145. . eCollection 2014.
   PubMed Web of Science ®Google Scholar
• Fullerton B, Erler A, Pohlmann B, et al. Predictors of dropout in the German disease management program for type 2 diabetes. BMC Health Ser Res. 2012;12(1):8. .
   Google Scholar
• Kauppila T, Laine MK, Honkasalo M, et al. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population. Scand J Prim Health Care. 2016;34(3):267–273.
   PubMed Web of Science ®Google Scholar
• Laine MK, Kauppila T, Honkasalo M, et al. Impact of intervention on metabolic outcomes among dropouts with type 2 diabetes. Adv Med Sci. 2017;63(1):5–8.
   Web of Science ®Google Scholar
• Kauppila T, Eriksson JG, Honkasalo M, et al. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care. Prim Care Diabetes. 2019;13(5):468–473.
   Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139.
   PubMed Web of Science ®Google Scholar
• Nichols GA, Joshua-Gotlib S, Parasuraman S. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study. J Gen Intern Med. 2013 May;28(5):691–697.
   Web of Science ®Google Scholar
• Feingold KR, Grunfeld G Diabetes and dyslipidemia, endotext. https://www.ncbi.nlm.nih.gov/books/NBK305900/
   Google Scholar
• de Havenon A, Majersik JJ, Tirschwell DL, et al. Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics. Neurology. 2019;92(11):e1168–e1175.
   Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572.
   PubMed Web of Science ®Google Scholar
• Zoungas S, Arima H, Gerstein HC, et al. Collaborators on Trials of Lowering Glucose (CONTROL) group. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431–437.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015;58(3):429–442.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 15. Diabetes Advocacy: standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1): S152–S153. .
   PubMedGoogle Scholar
• Standl E, Schnell O, McGuire DK, et al. Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes. Lancet Diabetes Endocrinol. 2017;5(5):391–402.
   PubMed Web of Science ®Google Scholar
• Gorter KJ, van de Laar FA, Janssen PG, et al. Diabetes: glycaemic control in type 2 (drug treatments). BMJ Clin Evid. 2012;0609:ii: 0609.
   Google Scholar
• Goudswaard AN, Lam K, Stolk RP, et al. Quality of recording of data from patients with type 2 diabetes is not a valid indicator of quality of care. A cross-sectional study. Fam Pract. 2003;20(2):173–177.
   PubMed Web of Science ®Google Scholar
• Modesti A, Bartaloni R, Bellagamba F, et al. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice. Prim Care Diabetes. 2015;9(1):9–14.
   Web of Science ®Google Scholar
• Fürthauer J, Flamm M, Sönnichsen A. Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study. BMC Fam Pract. 2013;14(1):47.
   Google Scholar
• Brugos-Larumbe A, Aldaz-Herce P, Guillen-Grima F, et al. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study. Prim Care Diabetes. 2018;12(1):34–44.
   Web of Science ®Google Scholar
• Staff M, Roberts C, March L. The completeness of electronic medical record data for patients with Type 2 Diabetes in primary care and its implications for computer modelling of predicted clinical outcomes. Prim Care Diabetes. 2016;10(5):352–359.
   Web of Science ®Google Scholar
• Mehta N, Stenholm S, Männistö S, et al. Excess body weight, cigarette smoking, and type II diabetes incidence in the national FINRISK studies. Ann Epidemiol. 2020 Feb;42:12–18. Epub 2020 Jan 9.
   Web of Science ®Google Scholar
• Ylihärsilä H, Lindström J, Eriksson JG, et al. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland. Diabet Med. 2005 Jan;22(1):88–91.
   Web of Science ®Google Scholar